İki uçlu bozuklukta bilişsel işlev bozukluklarının klinik belirleyicileri ve bilişsel ara fenotipler

Bilişsel işlev bozuklukları iki uçlu bozukluğun klinik düzelme dönemlerinde dahi hastaları etkilemektedir. Başta sözel öğrenme, sözel bellek ve yürütücü işlev bozuklukları olmak üzere faal bellek, dikkat, dikkati sürdürme ve işlem hızı iki uçlu bozuklukta öne çıkan alt bilişsel alanlardır. Sözel öğrenme ve sözel bellek hastaların yanında birinci derece akrabalarda da en fazla etkilenmiş işlevler olduklarından hastalıkla ilgili bir özellik olabilir, dolayısıyla bilişsel ara fenotip kavramına en uygun aday gibi görünmektedirler. Psikotik hastalık dönemlerinin olup olmaması, geçirilen hastalık dönemi tip ve sayıları, hastalığın başlangıç yaşı ve hastalık süresi bilişsel kayıpları etkilediği belirlenmiş klinik parametrelerdir. İki uçlu bozuklukların erken başlangıçlı formları, tip II bozukluk, yaşlılık ve komorbidite varlığı durumlarında bilişsel işlevlerin nasıl etkilendiği ile ilgili sınırlı sayıda araştırma bulunmaktadır. Ayrıca ilaçların bilişsel işlevleri kalitatif ve kantitatif olarak nasıl etkilediği ile ilgili yeterli ve tutarlı kanıt bulunmamaktadır. Hastaların birinci derece akrabalarında bilişsel kayıpların görülmesi ve kayıpların ailesel benzerlik göstermesi bilişsel işlevler için kalıtım göstergesi olabilir, bu nedenle araştırmaların desenlenmesinde genetik modellerin dikkate alınması önemli veriler sağlayabilir.

Clinic determinents of cognitive dysfunctions and cognitive endophenotypes in bipolar disorder

Cognitive dysfunctions influence patients with bipolar disorder even when they are clinically remitted. Verbal learning, verbal memory and executive functions foremost, working memory, (sustained) attention and processing speed are substantial cognitive domains in bipolar disorder. Dysfuntions in verbal learning and memory might be observed in first degree relatives as well; and thus seem to be best candidates for the cognitive endophenotype concept. Prior psychotic episodes, numbers and types of episodes, age of illness onset and duration of illness are clinical parameters seem to influence cognitive functions. There are relatively limited numbers of researches about cognitive dysfunctions in early onset forms, old age, type II disorder and comorbidity aspects of bipolar disorders. Results from the researches regarding qualitative and quantitative effects of medications on cognition are inconsistent. Cognitive deficits of first degree relatives and familial resemblance of deficits might be indicators of heritability of cognitive functions, therefore taking genetic models into account in designs of researches may provide considerable data.

___

  • 1. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001; 3:106-150.
  • 2. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002; 72:209–226.
  • 3. Savitz J, Solms M, Ramesar R. Neuropsycholgical dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 2005; 7:216-235.
  • 4. Basso MR, Lowery N, Neel J, Purdie R, Bornstein RA. Neuropsychological impairment among manic, depressed, and mixed-episode inpatients with bipolar disorder. Neuropsychology 2002; 16:84–91.
  • 5. Malhi GS, Lagopoulos J, Owen AM, Ivanovski B, Shnier R, Sachdev P. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord 2007; 97:109-122.
  • 6. Martinez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M. Cognitive function across manic or hypomanic,depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161:262-270.
  • 7. Murphy FC, Sahakian BJ. Neuropsychology of bipolar disorder. Br J Psychiatry 2001; 178 (Suppl.41):120-127.
  • 8. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180:313-319.
  • 9. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB. A metaanalysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93:105-115.
  • 10. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; 434:17-26.
  • 11. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their firstdegree relatives. Psychol Med 2008; 38:771-785.
  • 12. Mur M, Portella MJ, Martinez-Arán A, Pifarré J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthmic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand 2008; 118:373-381.
  • 13. Mesulam MM. From sensation to cognition. Brain 1998; 121:1013-1052.
  • 14. O’Reilly RC, Braver TS, Cohen JD. A biologically based computational model of working memory: In Miyake A, Shah P (editors). Models of working memory: Mechanisms of active maintenance and executive control. NY, USA: Cambridge University Press, 1999, 375–411.
  • 15. Price CJ, Friston KJ. Degeneracy and cognitive anatomy. Trends Cogn Sci 2002; 6:416–421.
  • 16. Miller EK. The prefrontal cortex: complex neural properties for complex behavior. Neuron 1999; 22:15–17.
  • 17. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24:167–202.
  • 18. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175:246–251.
  • 19. El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 2001; 3:79–87.
  • 20. van Gorp WG, Altshuler L, Theberge DC, Mintz J. Declarative and procedural memory in bipolar disorder. Biol Psychiatry 1999; 46:525–531.
  • 21. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004; 56:560-569.
  • 22. Zubieta JK, Huguelet P, O’Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001; 102:9–20.
  • 23. Wilder-Willis KE, Sax KW, Rosenberg HL, Fleck DE, Shear PK, Strakowski SM. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord 2001; 3:58–62.
  • 24. Rubinsztein JS, Michael A, Paykel ES, Sahakian BJ. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000; 30:1025–1036.
  • 25. Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, Young AH. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186:32–40.
  • 26. Scott J, Stanton B, Garland A, Ferrier IN. Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000; 30:467-472.
  • 27. Tham A, Engelbrektson K, Mathe AA, Johnson L, Olsson E, Aberg-Wistedt A. Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry 1997; 58:26–29.
  • 28. Baddeley A. The central executive: a concept and some misconceptions. J Int Neuropsychol Soc 1998; 4:523–526.
  • 29. Frangou S, Haldane M, Roddy D, Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol Psychiatry 2005; 58:838–839.
  • 30. Sapin LR, Berrettini WH, Nurnberger JI Jr, Rothblat LA. Mediational factors underlying cognitive changes and laterality in affective illness. Biol Psychiatry 1987; 22:979–986.
  • 31. Meyer SE, Carlson GA, Wiggs EA, Martinez PE, ROnsaville DS, Klimes-Dougan B, Gold PW, Radke-Yarrow M. A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder. Dev Psychopathol 2004; 16:461–476.
  • 32. Fuster JM. Memory in the cerebral cortex: An empirical approach to neural networks in the human and nonhuman primate. Cambridge, MA, USA: The Mit Press, 1995.
  • 33. Ericsson KA, Delaney PF. Long-term working memory as an alternative to capacity models of working memory in everyday skilled performance: In Miyake A, Shah P (editors). Models of working memory: Mechanisms of activemaintenance and executive control. NY, USA: Cambridge University Press, 1999, 257–297.
  • 34. Baddeley A. Working memory. Science 1992; 255:556–559. 35. Baddeley A. The fractionation of working memory. Proc Natl Acad Sci USA 1996; 93:13468–13472.
  • 36. Glahn DC, Bearden CE, Cakir S, Barret JA, Najt P, Serap Monkul E, Maples N, Velligan DI, Soares JC. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006; 8:117–123.
  • 37. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64:86–93.
  • 38. Bearden CE, Glahn DC, Monkul ES, Barret J, Najt P, Kaur S, Sanches M, Villareal V, Bowden C, Soares JC. Sources of declarative memory impairment in bipolar disorder: Mnemonic processes and clinical features. J Psychiatr Res 2005; 40:47-58.
  • 39. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158:1605–1611.
  • 40. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Casecontrol study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002; 180:320–326.
  • 41. Deckersbach T, Savage CR, Reilly-Harrington N, Clark L, Sachs G, Rauch SL. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar Disord 2004; 6:233–244.
  • 42. Fleck DE, Shear PK, Zimmerman ME, Getz GE, Corey KB, Jak A, Lebowitz BK, Strakowski SM. Verbal memory in mania: effects of clinical state and task requirements. Bipolar Disord 2003; 5:375–380.
  • 43. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, DixonW. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55:41–46.
  • 44. Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report. Bipolar Disord 2004; 6:319–322.
  • 45. Keri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001; 31:915–922.
  • 46. Sweeney JA, Kmiec JA, Kupfer DJ. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 2000; 48:674– 685.
  • 47. Henry GM, Weingartner H, Murphy DL. Influence of affective states and psychoactive drugs on verbal learning and memory. Am J Psychiatry 1973; 130:966–971.
  • 48. Martinez-Arán A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares- Seisdedos R, Ayuso-Mateos JL. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007; 9:103-113.
  • 49. Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen WJ. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 2002; 159:975–982.
  • 50. Addington J, Addington D. Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophr Res 1997; 23:197–204.
  • 51. Clark L, Goodwin GM. State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254:61–68.
  • 52. Fleck DE, Sax KW, Strakowski SM. Reaction time measures of sustained attention differentiate bipolar disorder from schizophrenia. Schizophr Res 2001; 52:251–259.
  • 53. Neuchterlein KH, Dawson ME, Ventura J, Miklowitz D, Konishi G. Information-processing anomalies in the early course of schizophrenia and bipolar disorder. Schizophr Res 1991; 5:195– 196.
  • 54. Sax KW, Strakowski SM, Keck PE Jr., McElroy SL, West SA, Stanton PA. Symptom correlates of attentional improvement following hospitalization for a first episode of affective psychosis. Biol Psychiatry 1998; 44:784–786.
  • 55. Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck PE Jr, Hawkins JM. Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry 1999; 156:139–141.
  • 56. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004; 6:171-182.
  • 57. Denicoff KD, Ali SO, Mirsky AF, et al. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord 1999; 56:67–73.
  • 58. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005; 58:859–864.
  • 59. Najt P, Glahn D, Bearden CE , Hatch JP, Monkul ES, Kaur S, Villarreal V, Bowden C, Soares JC. Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test. Neurosci Lett 2005; 379:22–126.
  • 60. Hawkins KA, Hoffman RE, Quinlan DM, Rakfeldt J, Docherty NM, Sledge WH. Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. J Neuropsychiatry Clin Neurosci 1997; 9:81–89.
  • 61. Murphy FC, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES, Sahakian BJ. Decision-making cognition in mania and depression. Psychol Med 2001; 31:679–693.
  • 62. Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Torrent C, Goikolea JM, Corbella B, Sánchez-Moreno J, Salamero M. Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology 2002; 46 (Suppl.1):16–21.
  • 63. McKay AP, Tarbuck AF, Shapleske J, McKenna PJ. Neuropsychological function in manic-depressive psychosis. Evidence for persistent deficits in patients with chronic, severe illness. Br J Psychiatry 1995;167:51-57
  • 64. Doyle AE, Wilens TE, Kwon A, Seidman LJ, Faraone SV, Fried R, Swezey A, Snyder L, Biederman J. Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry 2005; 58: 540-548.
  • 65. Bora E, Yücel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113:1–20.
  • 66. Joseph MF, Frazier TW, Youngstrom EA, Soares JC. A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. J Child Adelosc Psychopharmacol 2008; 18:595-605.
  • 67. Martino DJ, Igoa A, Marengo E, Scápola M, Ais ED, Strejilevich SA. Cognitive and motor features in elderly people with bipolar disorder. J Affect Disord 2008; 105:291-295.
  • 68. Young RC, Murphy CF, Heo M, Schulberg HC, Alexopoulos GS. Cognitive impairment in bipolar disorder in oldu age: literature review and findings in manic patients. J Affect Disord 2006; 92:125-131.
  • 69. Torrent C, Martinez-Arán A, Daban C, Sánchez-Moreno J, Comes M, Goikolea JM, Salamero M, Vieta E. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189:254-259.
  • 70. Bora E, Vahip S, Akdeniz F, Gonul AS, Eryavuz A, Ogut M, Alkan M. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord 2007; 9:468-477.
  • 71. Van Gorp WG, Altshuler L, Theberge DC, Wilkins J, DixonW. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55:41–46.
  • 72. Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disoder. J Clin Psychopharmacol 1988; 8:425-428.
  • 73. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009; 70:1588-1597.
  • 74. López-Jaramillo C, Lopera-Vásquez J, Ospina-Duque J, Gallo A, Cortez V, Palacio C, Torrent C Martinez-Arán A, Vieta E. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 2010 (in press)
  • 75. Rybakowski JK, Permoda-Osip A, Borkowska A. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol 2009; 19:791-795.
  • 76. Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu B, Atbasoglu EC. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 2007: 9 (Suppl.1):136–144.
  • 77. Balanzá-Martinez V, Selva G, Martinez-Arán A, Prickaerts J, Salazar J, González-Pinto A, Vieta E, Tabarés-Seisdedos R. Neurocognition in bipolar disorders—A closer look at comorbidities and medications. Eur J Pharmacol 2010; 626:87-96.
  • 78. Goldberg JF, Chengappa KN. Identifying and treating cognitive impairement in bipolar disorder. Biplar Disord 2009; 11 (Suppl.2):123-137.
  • 79. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56:162–168.
  • 80. Lenox H, Gould TD, Manji HF. Endophenotypes in bipolar disorder. Am J Med Genet 2002; 114:391–406.
  • 81. MacQueen GM, Hajek T, Alda M. The phenotypes of bipolar disorder: relevance for genetic investigations. Mol Psychiatry 2005; 10:811-826.
  • 82. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645.
  • 83. Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC. Neurocognitive endophenotypes in a multiplex multigenerational study of schizophrenia. Am J Psychiatry 2007; 164:813-819.
  • 84. Pantelis C, Yücel M, Bora E, Fornito A, Testa R, Brewer WJ, Velakoulis, Wood SJ. Neurobiological markers of illness onset in psychosis and schizophrenia: The search for moving target. Neuropsychol Rev 2009; 19:385-398.
  • 85. Snitz BE, Macdonald AW 3rd, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 2006; 32:179-194.
  • 86. McIntosh AM, Harrison LK, Forrester K, Lawrie SM, Johnstone EC. Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry 2005; 186:378–385.
  • 87. Balanzá-Martínez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, Vieta E, Tabarés-Seisdedos R. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 2008; 32:1426-1438.
  • 88. Frantom LV, Allen DN, Cross CL. Neurocognitive endophenotypes for bipolar disorder. Bipolar Disord 2008; 10:387–399.
  • 89. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008; 32:675-692.
  • 90. Sobczak S, Honig A, van Duinen MA, Maes M, Riedel WJ. Mood, prolactin and cortisol responses following intravenous L-tryptophan challenge: evidence for serotonergic vulnerability in first-degree relatives of bipolar patients. Int J Neuropsychopharmacol 2002; 5:249-254.
  • 91. Sobczak S, Honig A, Nicolson NA, Riedel WJ. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 2002; 27:834-842.
  • 92. Simonsen C, Sundet K, Vaskinn A, Birkenaes AB, Engh JA, Hansen CF, Jónsdóttir H, Ringen PA, Opjordsmoen S, Friis S, Andreassen OA. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord 2008; 10:245-255.
  • 93. Tabarés-Seisdedos R, Escámez T, Martínez-Giménez JA, Balanzá V, Salazar J, Selva G, Rubio C, Vieta E, Geijó-Barrientos E, Martínez-Arán A, Reiner O, Martínez S. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study. Neuroscience 2006; 139:1289-1300.
  • 94. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006; 60:93-105.
  • 95. Phillips ML, Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull 2007; 33:893-904.
  • 96. Duff K, Schoenberg MR, Scott JG, Adams RL. The relationship between executive functioning and verbal and visual learning and memory. Arch Clin Neuropsychol 2005; 20:111-122.
  • 97. Strakowski SM, DelBello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 2005; 10:105-116.
  • 98. McDonald C, Bullmore E, Sham P, Chitnis X, Wickham H, Bramon E, Murray RM. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61:974–984.
  • 99. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC, Charney DS, Gore JC, Krystal JH, Peterson BS. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003; 60:601–609.
  • 100. Cornblatt BA, Malhotra AK. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 2001; 105:11-15.
  • 101. Szöke A, Schürhoff F, Golmard JL, Alter C, Roy I, Méary A, Etain B, Bellivier F, Leboyer M. Familial resemblance for executive functions in families of schizophrenic and bipolar patients. Psychiatry Res 2006; 144:131-138.
  • 102. Kuntsi J, Rogers H, Swinard G, Börger N, van der Meere J, Rijsdijk F, Asherson P. Reaction time, inhibition, working memory and ‘delay aversion’ performance: genetic influences and their interpretation. Psychol Med 2006; 36:1613-1624.
  • 103. Antila M, Tuulio-Henriksson A, Kieseppä T, Soronen P, Palo OM, Paunio T, Haukka J, Partonen T, Lönnqvist J. Heritability of cognitive functions in families with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:802-808.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi-Cover
  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984
  • Yayıncı: Kare Yayıncılık
Sayıdaki Diğer Makaleler

İki uçlu bozuklukta bilişsel işlev bozukluklarının klinik belirleyicileri ve bilişsel ara fenotipler

MURAT İLHAN ATAGÜN, Özlem Devrim BALABAN, KÜRŞAT ALTINBAŞ, Sema YEŞİLYURT, Devran TAN

Tek doz sertralin kullanımıyla ortaya çıkan bir panik atak olgusu

SEVDA KORKMAZ, Murat KULOĞLU, Umuıt IŞIK, Mustafa Nuray NAMLI, HASAN KORKMAZ, Murad ATMACA

Tıpta uzmanlık sınavına hazırlanan öğrencilerin psikiyatri asistanlığı hakkındaki tutumları

Murat EMÜL, Mihriban DALKIRAN, Sümeyye UZUNOĞLU, Musa TOSUN, Alaattin DURAN, Ruhi YAVUZ, Müfit UĞUR

Ön yazı

Cüneyt EVREN

Frontotemporal demans: Bir olgu sunumu

Nesim KUĞU, Orhan DOĞAN, Önder KAVAKÇI, İbrahim TERLEMEZ

Sağlık çalışanlarında vardiyalı çalışma sisteminin sebep olduğu genel ruhsal belirtiler ve yaşam kalitesi üzerine etkisi

Yavuz SELVİ, Güzel Pınar ÖZDEMİR, Osman ÖZDEMİR, Adem AYDIN, LÜTFULLAH BEŞİROĞLU

Edirne ili merkezindeki lise öğrencilerinde obsesif-kompulsif bozukluğun epidemiyolojisi

ERCAN ABAY, Aykan PULULAR, ÇAĞDAŞ ÖYKÜ MEMİŞ, Necdet SÜT

Novelty seeking among relapsed and non-relapsed male alcohol dependents during 12 month follow-up

Cüneyt EVREN, Mine DURKAYA, Samet KÖSE, Rabia ÇETİN, ERCAN DALBUDAK, Selime ÇELİK

Beyin kitle lezyonlarında bilgisayarlı tomografi eşliğinde yapılan stereotaktik biyopsinin tanı değeri: 100 olgunun histopatolojik değerlendirilmesi

BEKİR TUĞCU, Osman TANRIVERDİ, Abuzer GÜNGÖR, ŞEVKİ SERHAT BAYDIN, Lütfi Şinaşi POSTACI, Bülent Timur DEMİRGİL, Sinem GÖNENLİ

Klozapine bağlı siyalorenin patofizyolojisi ve güncel tedavi seçenekleri

Sema YEŞİLYURT, İmer ARAS, Kürşat ALTINBAŞ, MURAT İLHAN ATAGÜN, Erhan KURT